Mirum Pharmaceuticals Plans Supplemental New Drug Application Submission In H1 2027 To Expand Indication To Pediatric Patients Aged 6 To <12 Years.
Share
Why It Matters
Mirum is working to let kids ages 6 to 12 use their medicine. This shows the company believes in the drug's future and wants to help more patients.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.